norepinephrine dopamine disinhibitors nddis class drugs act specific sites disinhibit downstream norepinephrine dopamine release agomelatine antidepressant disinhibits norepinephrine dopamine release frontal cortex antagonizing first drug described many drugs also antagonize receptors degree another tend nonspecific actions result term nddi generally though always instance fluoxetine called nddi addition ssri due weak blockade reserved describing newer selective agents disinhibition norepinephrine dopamine release primary mechanism action another drug referred nddi medical literature approved treatment hypoactive sexual desire disorder premenopausal flibanserin disinhibits norepinephrine dopamine release prefrontal cortex activating receptors aside agomelatine fluoxetine flibanserin present drugs described nddis medical literature despite fact many existing drugs possess effects consistent definition nddi case drugs labeled specifically nddis may seen future